Bank of New York Mellon
RGLS

Bank of New York Mellon’s Regulus Therapeutics RGLS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-149,355
Closed -$261K 4223
2025
Q1
$261K Hold
149,355
﹤0.01% 3746
2024
Q4
$236K Sell
149,355
-1
-0% -$2 ﹤0.01% 3864
2024
Q3
$234K Sell
149,356
-47,837
-24% -$75.1K ﹤0.01% 3854
2024
Q2
$352K Buy
+197,193
New +$352K ﹤0.01% 3737
2019
Q1
Sell
-27,298
Closed -$25K 4229
2018
Q4
$25K Sell
27,298
-6,890
-20% -$6.31K ﹤0.01% 4131
2018
Q3
$7K Hold
34,188
﹤0.01% 4222
2018
Q2
$23K Sell
34,188
-33,260
-49% -$22.4K ﹤0.01% 4152
2018
Q1
$49K Buy
67,448
+30,696
+84% +$22.3K ﹤0.01% 4159
2017
Q4
$39K Buy
36,752
+2,563
+7% +$2.72K ﹤0.01% 4217
2017
Q3
$43K Buy
34,189
+9,730
+40% +$12.2K ﹤0.01% 4129
2017
Q2
$24K Sell
24,459
-91,941
-79% -$90.2K ﹤0.01% 4214
2017
Q1
$192K Sell
116,400
-16,819
-13% -$27.7K ﹤0.01% 3890
2016
Q4
$299K Sell
133,219
-3,558
-3% -$7.99K ﹤0.01% 3782
2016
Q3
$452K Sell
136,777
-4,439
-3% -$14.7K ﹤0.01% 3590
2016
Q2
$408K Buy
141,216
+20,118
+17% +$58.1K ﹤0.01% 3620
2016
Q1
$839K Sell
121,098
-8,527
-7% -$59.1K ﹤0.01% 3170
2015
Q4
$1.13M Buy
129,625
+12,323
+11% +$107K ﹤0.01% 3083
2015
Q3
$767K Sell
117,302
-23,402
-17% -$153K ﹤0.01% 3321
2015
Q2
$1.54M Buy
140,704
+67,360
+92% +$738K ﹤0.01% 3078
2015
Q1
$1.24M Buy
73,344
+373
+0.5% +$6.32K ﹤0.01% 3175
2014
Q4
$1.17M Buy
72,971
+9,573
+15% +$153K ﹤0.01% 3214
2014
Q3
$433K Buy
63,398
+42
+0.1% +$287 ﹤0.01% 3680
2014
Q2
$509K Buy
63,356
+4,743
+8% +$38.1K ﹤0.01% 3600
2014
Q1
$529K Sell
58,613
-570
-1% -$5.14K ﹤0.01% 3563
2013
Q4
$437K Buy
59,183
+1,474
+3% +$10.9K ﹤0.01% 3606
2013
Q3
$544K Sell
57,709
-115
-0.2% -$1.08K ﹤0.01% 3479
2013
Q2
$568K Buy
+57,824
New +$568K ﹤0.01% 3439